CVSI · CV Sciences, Inc.

Summary

CV Sciences, Inc. filed an 8-K on March 10, 2026, disclosing a material definitive agreement entered into on February 12, 2025, which also created a direct financial obligation and involved an unregistered securities offering. Exhibits 10.1 and 10.2 reference the agreement dated March 4, 2026, with confidential portions omitted.

Key takeaways

• Entered into material definitive agreement on February 12, 2025
• Agreement creates direct financial obligation under Item 2.03
• Unregistered securities issued in reliance on Securities Act exemption under Item 3.02
• Exhibit 10.1: Agreement dated March 4, 2026 with confidential portions omitted
• Exhibit 10.2 referenced in filing